These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunohistochemical validation of TLE1, a novel marker, for synovial sarcomas. Rekhi B; Basak R; Desai SB; Jambhekar NA Indian J Med Res; 2012 Nov; 136(5):766-75. PubMed ID: 23287123 [TBL] [Abstract][Full Text] [Related]
5. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases. Knösel T; Heretsch S; Altendorf-Hofmann A; Richter P; Katenkamp K; Katenkamp D; Berndt A; Petersen I Eur J Cancer; 2010 Apr; 46(6):1170-6. PubMed ID: 20189377 [TBL] [Abstract][Full Text] [Related]
6. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas. Rekhi B; Vogel U APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315 [TBL] [Abstract][Full Text] [Related]
7. [Roles of immunohistochemistry and detection of SYT-SSX fusion gene in diagnosis of synovial sarcoma]. Sun Y; Sun BC; Zhao XL; Wang J; Chen J; Li XQ; Feng YM; Fang ZW; Hao XS Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):480-4. PubMed ID: 17845763 [TBL] [Abstract][Full Text] [Related]
8. TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms. Kosemehmetoglu K; Vrana JA; Folpe AL Mod Pathol; 2009 Jul; 22(7):872-8. PubMed ID: 19363472 [TBL] [Abstract][Full Text] [Related]
9. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Terry J; Saito T; Subramanian S; Ruttan C; Antonescu CR; Goldblum JR; Downs-Kelly E; Corless CL; Rubin BP; van de Rijn M; Ladanyi M; Nielsen TO Am J Surg Pathol; 2007 Feb; 31(2):240-6. PubMed ID: 17255769 [TBL] [Abstract][Full Text] [Related]
10. [Application of TLE1 expression and fluorescence in-situ hybridization in diagnosing poorly differentiated synovial sarcoma]. Mao RJ; Li QM; Fang HQ; Han FL; Huang XF; Wu YX; Zeng M Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):403-5. PubMed ID: 21914350 [No Abstract] [Full Text] [Related]
11. Expression of TLE1, INI1, β-catenin, Claudin1, CK7, CK19, SS18 and calponin in synovial sarcoma. Madakshira MG; Radotra BD; Kaman L; Saikia UN Indian J Pathol Microbiol; 2021; 64(4):707-716. PubMed ID: 34673590 [TBL] [Abstract][Full Text] [Related]
12. Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcoma. van de Rijn M; Barr FG; Collins MH; Xiong QB; Fisher C Am J Clin Pathol; 1999 Jul; 112(1):43-9. PubMed ID: 10396284 [TBL] [Abstract][Full Text] [Related]
13. Utility of Immunohistochemistry With Antibodies to SS18-SSX Chimeric Proteins and C-Terminus of SSX Protein for Synovial Sarcoma Differential Diagnosis. Lasota J; Chłopek M; Kaczorowski M; Natálie K; Ryś J; Kopczyński J; Sulaieva O; Michal M; Kruczak A; Harazin-Lechowska A; Szczepaniak M; Koshyk O; Hałoń A; Czapiewski P; Abdullaev Z; Kowalik A; Aldape KD; Michal M; Miettinen M Am J Surg Pathol; 2024 Jan; 48(1):97-105. PubMed ID: 37899499 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic utility of dual-color break-apart chromogenic in situ hybridization for the detection of rearranged SS18 in formalin-fixed, paraffin-embedded synovial sarcoma. Motoi T; Kumagai A; Tsuji K; Imamura T; Fukusato T Hum Pathol; 2010 Oct; 41(10):1397-404. PubMed ID: 20594581 [TBL] [Abstract][Full Text] [Related]
15. The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study. Ito J; Asano N; Kawai A; Yoshida A Hum Pathol; 2016 Jan; 47(1):32-7. PubMed ID: 26520417 [TBL] [Abstract][Full Text] [Related]
16. TLE1 is expressed in the majority of primary pleuropulmonary synovial sarcomas. Lino-Silva LS; Flores-Gutiérrez JP; Vilches-Cisneros N; Domínguez-Malagón HR Virchows Arch; 2011 Dec; 459(6):615-21. PubMed ID: 22071579 [TBL] [Abstract][Full Text] [Related]
17. When used together SS18-SSX fusion-specific and SSX C-terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most cases. Zaborowski M; Vargas AC; Pulvers J; Clarkson A; de Guzman D; Sioson L; Maclean F; Chou A; Gill AJ Histopathology; 2020 Oct; 77(4):588-600. PubMed ID: 32559341 [TBL] [Abstract][Full Text] [Related]
18. Transducer-like enhancer of split 1 (TLE1) expression as a diagnostic immunohistochemical marker for synovial sarcoma and its association with morphological features. Bakrin IH; Hussain FA; Tuan Sharif SE Malays J Pathol; 2016 Aug; 38(2):117-22. PubMed ID: 27568668 [TBL] [Abstract][Full Text] [Related]
19. Expression of TLE1 in Malignant Melanoma With Spindle Cell Morphology: A Potential Diagnostic Pitfall. Morrell TJ; Xiong Y; Deng A; Dresser K; O'Donnell P; Cornejo KM Int J Surg Pathol; 2019 May; 27(3):259-262. PubMed ID: 30301396 [TBL] [Abstract][Full Text] [Related]
20. Transducer-like Enhancer of Split 1 as a Novel Immuno- histochemical Marker for Diagnosis of Synovial Sarcoma. Atef A; Alrashidy M Asian Pac J Cancer Prev; 2015; 16(15):6545-8. PubMed ID: 26434872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]